Cancer-associated rs6983267 SNP and its accompanying long noncoding RNACCAT2induce myeloid malignancies via unique SNP-specific RNA mutations

Authors:

Abstract
The cancer-risk-associated rs6983267 single nucleotide polymorphism (SNP) and the accompanying long noncoding RNACCAT2in the highly amplified 8q24.21 region have been implicated in cancer predisposition, although causality has not been established. Here, using allele-specificCCAT2transgenic mice, we demonstrate thatCCAT2overexpression leads to spontaneous myeloid malignancies. We further identified thatCCAT2is overexpressed in bone marrow and peripheral blood of myelodysplastic/myeloproliferative neoplasms (MDS/MPN) patients.CCAT2induces global deregulation of gene expression by down-regulating EZH2 in vitro and in vivo in an allele-specific manner. We also identified a novel non-APOBEC, non-ADAR, RNA editing at the SNP locus in MDS/MPN patients andCCAT2-transgenic mice. The RNA transcribed from the SNP locus in malignant hematopoietic cells have different allelic composition from the corresponding genomic DNA, a phenomenon rarely observed in normal cells. Our findings provide fundamental insights into the functional role of rs6983267 SNP andCCAT2in myeloid malignancies.
Funding Information
  • National Institutes of Health (1UH2TR00943-01)
  • National Cancer Institute (1 R01 CA182905-01)
  • National Cancer Institute (P50 CA093459)
  • Melanoma Foundation (2P50CA127001)
  • Center for Radiation Oncology Research Project
  • Center for Cancer Epigenetics Pilot
  • SINF
  • RGK Foundation
  • National Institutes of Health (R01 CA164346)
  • National Cancer Institute (1R01 CA200703-01A1)
  • Leukemia SPORE (P50 CA100632, CPRIT RP140402)
  • Sister Institution Network Fund
  • Vetenskapsrådet
  • Cancerfonden
  • the Swedish Childhood Cancer foundation
  • Crown Princess Margareta's Foundation
  • SINF StraCan, King Gustaf V Jubilee Foundation
  • Stockholm Cancer Society
  • Stockholm county
  • Karolinska Institutet